一、个人信息
姓名：程艳洁
技术职务：讲师
学位：博士
研究领域：药食同源中药用于代谢功能障碍相关的脂肪性肝炎的药理药效研究
Email: chengyj@ahstu.edu.cn
二、个人简介
研究领域主要为药食同源中药用于代谢功能障碍相关的脂肪性肝炎的药理药效研究及非酒精性脂肪肝病（NAFLD）双靶点小核酸药物的成药性研究等。相关成果发表在Science Translational Medicine, Molecular Therapy - Nucleic Acids及Frontiers in Cell and Developmental Biology等期刊上，主持安徽省教育厅重点研发项目及安徽科技学院人才引进项目等项目资助。
三、教育经历
2012.09-2018.06，华中农业大学，基础兽医学，博士
2008.09-2012.06，西北农林科技大学，动物科学，学士
四、工作经历
2022.05-至今，安徽科技工程大学，生物医学与健康学院，讲师
2018.07 至 2021.06, 武汉大学, 中南医院, 助理研究员
五、主持课题
1. 安徽省教育厅重点项目，山楂黄芪配伍治疗MAFLD成药性与分子机理研究，2025.12-2027.12。
2. 安徽科技学院人才引进项目，非酒精性脂肪肝病（NAFLD）双靶点小核酸药物的成药性研究，2022.09-2030.08。
六、代表性论文
1. Xiao-Jing Zhang; Yan-Xiao Ji; Xu Cheng; Yanjie Cheng; Hailong Yang; Junyong Wang; Ling-Ping Zhao; Yong-Ping Huang; Dating Sun; Hui Xiang; Li-Jun Shen; Peng-Long Li; Jun-Peng Ma; Rui-Feng Tian; Juan Yang; Xinxin Yao; Haibo Xu; Rufang Liao; Li Xiao; Peng Zhang; Xin Zhang; Guang-Nian Zhao; Xi Wang; Man-Li Hu; Song Tian; Juan Wan; Jingjing Cai; Xinliang Ma; Qingbo Xu; YibinWang; Rhian M. Touyz; Peter P. Liu; Rohit Loomba; Zhi-Gang She; Hongliang Li; A small molecule targeting ALOX12-ACC1 ameliorates nonalcoholic steatohepatitis in mice and macaques, Science Translational Medicine, 2021, 13(624): 1-15
2. Yanjie Cheng; Wei Zhuying; Xie Shengsong; Peng You; Yan Yi; Qin Dan; Liu Shenghui; Xu
Yanling; Li Guangpeng; Zhang Lisheng; Alleviation of Toxicity Caused by Overactivation of Ppara through Ppara-Inducible miR-181a2, Molecular Therapy - Nucleic Acids, 2017, 9(9)
3. Zhang, Xiao-Jing; She, Zhi-Gang; Wang, Junyong; Sun, Dating; Shen, Li-Jun; Xiang, Hui;
Cheng, Xu; Ji, Yan-Xiao; Huang, Yong-Ping; Li, Peng-Long; Yang, Xia; Yanjie Cheng; Ma, Jun-Peng;Wang, Hai-Ping; Hu, Yufeng; Hu, Fengjiao; Tian, Song; Tian, Han; Zhang, Peng; Zhao, Guang-Nian;Wang, Lin; Hu, Man-; Multiple omics study identifies an interspecies conserved driver for nonalcoholic steatohepatitis, Science Translational Medicine, 2021, 13(624): 1-16
4. Jin-he Jiang; Ru-tong Ren; Yan-jie Cheng; Xin-xin Li; Gui-rong Zhang; Immune cells and
RBCs derived from human induced pluripotent stem cells: method, progress, prospective challenges, Frontiers in Cell and Developmental Biology, 2024, 11(1327466)
